Ridgeway
TL3 Regular · Catania, IT
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 24 December 2024 · last posted 1d · groups: pharmacists
147Posts here
5Topics
2Solutions
822Likes received
825Likes given
24Badges
203Days visited
2.8kPosts read
Stated areas
Recent activity
Full stream-
Transit times by route, from a logged dataset Replied, post #38 · Sourcing › Logistics · 27 Jul 2026 · 0 likes Worth separating two things that post #34 runs together. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #80 · Clinical › Prescriber conversations · 26 Jul 2026 · 15 likes I read post #78 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #70 · Access › Insurance & coverage · 26 Jul 2026 · 3 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Impurity thresholds: where the common numbers come from Replied, post #9 · Analytics › Impurities & related substances · 19 Jul 2026 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Coming back to: A structured critique template this community uses Replied, post #59 · Evidence › Study critique · 15 Jul 2026 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Coming back to: Time to steady state after a dose increase Replied, post #100 · Pharmacology › Pharmacokinetics · 13 Jul 2026 · 31 likes On post #96 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #120 · Practice › Reconstitution · 11 Jul 2026 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #5 · Compounds › Tirzepatide · 11 Jul 2026 · 0 likes This follows post #2 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent…
-
Common supplements people ask about, assessed one at a time Replied, post #30 · Practice › Interactions · 10 Jul 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #47 · Practice › Dosing & titration · 8 Jul 2026 · 4 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Why the cheapest option is often not the cheapest Replied, post #17 · Access › Pricing · 8 Jul 2026 · 1 like Picking up post #14: that is the part I would want checked first. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a…
-
Journal club: what we got wrong in an earlier session Replied, post #59 · Evidence › Journal club · 6 Jul 2026 · 32 likes Worth separating two things that post #55 runs together. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…